COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,761 Articles (22,502 medRxiv, 8,259 bioRxiv)

Most recent first Previous |  Page 3010: Articles 30091-30100  | Next

Incidence, clinical characteristics and prognostic factor of patients with COVID-19: a systematic review and meta-analysis
Zhao, X., Zhang, B., Li, P., Ma, C., Gu, J., Hou, P., Guo, Z., Wu, H., Bai, Y.
10.1101/2020.03.17.20037572 — Posted: 2020-03-20
A framework for identifying regional outbreak and spread of COVID-19 from one-minute population-wide surveys
Rossman, H., Keshet, A., Shilo, S., Gavrieli, A., Bauman, T., Cohen, O., Balicer, R., Geiger, B., Dor, Y., Segal, E.
10.1101/2020.03.19.20038844 — Posted: 2020-03-20
Hydroxychloroquine and Azithromycin as a treatment of COVID-19: preliminary results of an open-label non-randomized clinical trial
GAUTRET, P., LAGIER, J. C., PAROLA, P., HOANG, V. T., MEDDED, L., MAILHE, M., DOUDIER, B., COURJON, J., GIORDANENGO, V., ESTEVES VIEIRA, V., TISSOT DUPONT, H., HONORE, S., COLSON, P., CHABRIERE, E., LA SCOLA, B., ROLAIN, J. M., BROUQUI, P., RAOULT, D.
10.1101/2020.03.16.20037135 — Posted: 2020-03-20 Discussion: Onsite | Offsite
Estimating Preventable COVID19 Infections Related to Elective Outpatient Surgery in Washington State: A Quantitative Model
Zhang, Y., Cheng, S.-R.
10.1101/2020.03.18.20037952 — Posted: 2020-03-20
A brief review of antiviral drugs evaluated in registered clinical trials for COVID-19
Belhadi, D., Peiffer-Smadja, N., Yazdanpanah, Y., Mentre, F., Laouenan, C.
10.1101/2020.03.18.20038190 — Posted: 2020-03-20 Discussion: Onsite
Tracing DAY-ZERO and Forecasting the Fade out of the COVID-19 Outbreak in Lombardy, Italy: A Compartmental Modelling and Numerical Optimization Approach.
Russo, L., Anastassopoulou, C., Tsakris, A., Bifulco, G. N., Campana, E. F., Toraldo, G., Siettos, C.
10.1101/2020.03.17.20037689 — Posted: 2020-03-20 Discussion: Onsite
Reverse transcription loop-mediated isothermal amplification combined with nanoparticles-based biosensor for diagnosis of COVID-19
Zhu, X., Wang, X., Han, L., Chen, T., Wang, L., Li, H., Li, S., He, L., Fu, X., Chen, S., Mei, X., Chen, H., Wang, Y.
10.1101/2020.03.17.20037796 — Posted: 2020-03-20
Chinese Public Attention to COVID-19 Epidemic: Based on Social Media
Zhao, Y., Xu, H.
10.1101/2020.03.18.20038026 — Posted: 2020-03-20
Estimating the Risks from COVID-19 Infection in Adult Chemotherapy Patients
Williams, M., Le Calvez, K., Mi, E., Chen, J., Dadhania, S., Pakzad-Shahabi, L.
10.1101/2020.03.18.20038067 — Posted: 2020-03-20
Spatial Visualization of Cluster-Specific COVID-19 Transmission Network in South Korea During the Early Epidemic Phase
Park, J. Y.
10.1101/2020.03.18.20038638 — Posted: 2020-03-20

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).